---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-030244"
form_type: "8-K"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2024-06-27T23:59:59+00:00"
generated_at: "2026-06-01T01:06:49.757285+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# GRI Bio prices $4.0M public offering of shares and warrants at $1.83/unit

## Summary
- Offering of 2,185,793 shares (or equivalents) plus Series C-1 and C-2 warrants at $1.83 per unit.
- Gross proceeds ~$4.0M, net proceeds ~$3.2M after 7% placement agent fee and expenses.
- Warrants exercisable at $1.83/share upon stockholder approval; C-1 expires 5 yrs, C-2 expires 18 months.
- Proceeds allocated to product candidate development, working capital, and general corporate purposes.
- H.C. Wainwright is exclusive placement agent; closing expected on or about June 28, 2024.

## SEC filing metadata
- accession: 0001628280-24-030244
- form_type: 8-K
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2024-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000162828024030244/0001628280-24-030244-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000162828024030244/val-20240626.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-030244
- JSON: https://secwatch.observer/filing/0001628280-24-030244.json
- Plain text: https://secwatch.observer/filing/0001628280-24-030244.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.